Scancell Holdings plc Stock
Stocks
SCLP
GB00B63D3314
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.00 GBX | -4.76% |
|
-18.13% | +57.12% |
| 06-28 | Scancell Is in Talks over Possible Equity and Debt Financing | CI |
| 06-26 | Neuphoria Confirms Business Combination Talks With Scancell | MT |
| Market Cap | 174M 232M 203M 187M 329M 22.01B 335M 2.25B 872M 10.8B 869M 850M 37.6B | P/E 2026 * |
-11.2x | P/E 2027 * | -21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 185M 245M 215M 198M 348M 23.33B 356M 2.38B 924M 11.45B 921M 901M 39.85B | EV / Sales 2026 * |
148x | EV / Sales 2027 * | 79.3x |
| Free-Float |
96.34% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Scancell Holdings plc
| 1 day | -4.17% | ||
| 1 week | -15.26% | ||
| Current month | -8.00% | ||
| 1 month | -32.21% | ||
| 3 months | +43.11% | ||
| 6 months | +62.63% | ||
| Current year | +62.63% |
| 1 week | 15.56 |  | 20 |
| 1 month | 15.56 | | 24 |
| Current year | 9.5 | | 29.5 |
| 1 year | 7.86 | | 29.5 |
| 3 years | 7.26 | | 29.5 |
| 5 years | 7.26 | | 29.5 |
| 10 years | 0.11 | | 29.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Durrant
CEO | Chief Executive Officer | 69 | 28/07/2021 |
| Chief Executive Officer | 64 | 18/11/2024 | |
David Schilansky
DFI | Director of Finance/CFO | 50 | 24/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Durrant
BRD | Director/Board Member | 69 | 17/11/2010 |
Ursula Ney
BRD | Director/Board Member | 74 | 23/10/2019 |
Susan Davies
BRD | Director/Board Member | 64 | 24/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/09/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 3,150,000 | 0.3038% | |
| 08/08/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 102,236 | 0.0099% | |
| 04/08/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 4,400,000 | 0.4244% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.17% | -15.26% | +69.47% | +21.51% | 232M | |
| +0.05% | +4.65% | +0.61% | +6.20% | 48.62B | |
| +0.12% | +10.45% | +408.29% | +600.97% | 39.86B | |
| +5.17% | +9.47% | +24.96% | -9.60% | 33.91B | |
| +2.02% | +4.91% | +18.59% | +63.06% | 32.32B | |
| +0.69% | +1.04% | +14.23% | +30.86% | 24.73B | |
| +0.40% | +12.51% | - | - | 16.63B | |
| +2.64% | +6.00% | +69.30% | +126.33% | 15.52B | |
| 0.00% | +0.26% | +12.86% | +17.55% | 13.63B | |
| +0.77% | +10.67% | +17.58% | -30.04% | 13.41B | |
| Average | +0.78% | +4.54% | +70.66% | +91.87% | 23.89B | |
| Weighted average by Cap. | +1.36% | +7.12% | +88.23% | +128.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.25M 1.66M 1.46M 1.34M 2.36M 158M 2.41M 16.13M 6.25M 77.46M 6.23M 6.1M 270M | 2.4M 3.19M 2.8M 2.58M 4.53M 303M 4.62M 30.98M 12M 149M 11.97M 11.71M 518M |
| Net income | -19.23M -25.54M -22.42M -20.64M -36.27M -2.43B -37.01M -248M -96.19M -1.19B -95.9M -93.82M -4.15B | -8.24M -10.94M -9.6M -8.84M -15.53M -1.04B -15.85M -106M -41.19M -510M -41.07M -40.18M -1.78B |
| Net Debt | 10.42M 13.83M 12.14M 11.18M 19.64M 1.32B 20.04M 134M 52.09M 646M 51.94M 50.81M 2.25B | 15.87M 21.08M 18.51M 17.04M 29.94M 2B 30.55M 205M 79.39M 984M 79.15M 77.43M 3.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | GBX 16.00 | -4.76% | 2,379,200 |
| 01/07/26 | GBX 16.80 | -4.00% | 1,615,746 |
| 30/06/26 | GBX 17.50 | +4.48% | 2,319,559 |
| 29/06/26 | GBX 16.75 | -8.97% | 4,565,791 |
| 26/06/26 | GBX 18.40 | -3.16% | 4,775,172 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCLP Stock
Select your edition
All financial news and data tailored to specific country editions
